Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1275-1279

  Carneiro, José Ronaldo M ^a   Sato, Emília Inoue ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Methotrexate; Randomized clinical trial; Systemic lupus erythematosus

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; LIVER DISEASE; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; URTICARIA;

ADULT; ARTHRALGIA; ARTHRITIS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EXANTHEMA; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHOTREXATE; PLACEBOS; PREDNISONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0033000295     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weinblatt ME. Methotrexate. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1993.
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982;25:1271-7.
3. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang C-H, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
4. Ferraz MB, Quaresma MR, Aquino LRL, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990;17:1022-4.
5. Miescher PA, Riethmüller D. Diagnosis and treatment of systemic lupus erythematosus. Semin Hematol 1965;2:1-28.
6. Davidson JR, Graziano FM, Rothenberg RJ. Methotrexate therapy for severe systemic lupus erythematosus. Arthritis Rheum 1987;30:1195-6.
7. Rothenberg RJ, Graziano FM, Grandone JT, Goldberg JW, Bjarnason DF, Finesilver AG. The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum 1988;31:612-5.
8. Wilson K, Abeles M. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1994;21:1674-7.
9. Wilke WS, Krall RJ, Scheetz TB, et al. Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 1991;9:581-7.
10. Arfi S, Numeric P, Grollier L, Panelatti G, Jean-Baptiste G. Traitement du lupus érythémateux systemique corticodépendant par le methotrexate à faibles doses. Rev Méd Interne 1995;16:885-90.
11. Abud-Mendoza C, Sturbaum AK, Vasquez-Compean R, Gonzalez-Amaro R. Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol 1993;20:731-3.
12. Wise CM, Vuyyuru S, Roberts WN. Methotrexate in non-renal lupus and undifferentiated connective tissue disease - a review of 36 patients. J Rheumatol 1996;23:1005-10.
13. Galarza D, Esquivel J, Villarreal M, de la Garza N, Garza M. Methotrexate in lupus nephritis: an uncontrolled study, preliminary results [abstract]. Arthritis Rheum 1992;Suppl 34:S187.
14. Gansauge S, Breitbart A, Rinaldi N, Schwarz-Eywill M. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). Ann Rheum Dis 1997;56:382-5.
15. Kipen Y, Littlejohn GO, Morand EF. Methotrexate use in systemic lupus erythematosus. Lupus 1997;6:385-9.
16. Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol 1998;25:243-6.
17. Dubois EL. Management of discoid and systemic lupus erythematosus. Lupus erythematosus: A review of the current status of discoid and systemic lupus erythematosus and their variants. In: Dubois EL, editor. Systemic lupus erythematosus. Los Angeles: University of Southern California Press; 1974:537-612.
18. Lemense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med 1994;150:258-60.
19. Schnabel A, Burchardi C, Gross WL. Major infection during methotrexate treatment for rheumatoid arthritis. Semin Arthritis Rheum 1996;25:357-9.
20. Salaffi F, Carotti M, Sarini A, Cervini C. A prospective study of the longterm efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis. Clin Exp Rheumatol 1994;13:23-8.